Eton Pharmaceuticals (ETON) holder Opaleye reports July stock sales
Rhea-AI Filing Summary
Opaleye Management Inc., a more-than-10% holder of Eton Pharmaceuticals, reported open-market sales totaling 28,315 shares of common stock on July 14, 2026 at a weighted average price of $37.5431 per share. The sales consisted of 13,315 shares held in a separately managed account and 15,000 shares held by Opaleye, L.P. Following these transactions, the managed account held 40,000 shares and Opaleye, L.P. held 2,665,000 shares, all reported as indirect holdings. Opaleye Management may be deemed to beneficially own these securities but disclaims beneficial ownership except to the extent of its pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 28,315 shares
Net Sell
2 txns
Insider
Opaleye Management Inc.
Role
10% Owner
Sold
28,315 shs ($1.06M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.001 per share F3, F1, F4 | 15,000 | $37.5431 | $563K |
| Sale | Common Stock, par value $0.001 per share F3, F2, F4 | 13,315 | $37.5431 | $500K |
Holdings After Transaction:
Common Stock, par value $0.001 per share — 2,665,000 shares (Indirect, By Opaleye, L.P.);
Common Stock, par value $0.001 per share — 40,000 shares (Indirect, By Managed Account)
Footnotes (4)
- F1. Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund.
- F2. Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Managed Account.
- F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.0152 to $37.9148 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- F4. Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Key Figures
Shares sold via Managed Account: 13,315 shares
Shares sold via Opaleye, L.P.: 15,000 shares
Total shares sold: 28,315 shares
+4 more
7 metrics
Shares sold via Managed Account
13,315 shares
Open-market sale on 2026-07-14 by separately managed account
Shares sold via Opaleye, L.P.
15,000 shares
Open-market sale on 2026-07-14 by Opaleye, L.P.
Total shares sold
28,315 shares
Combined open-market sales reported for 2026-07-14
Weighted average sale price
$37.5431 per share
Weighted average for sales on 2026-07-14
Sale price range
$37.0152–$37.9148 per share
Range of prices for multiple sale transactions
Shares held by Managed Account after sale
40,000 shares
Indirectly owned through separately managed account
Shares held by Opaleye, L.P. after sale
2,665,000 shares
Indirectly owned through Opaleye, L.P.
Key Terms
weighted average price, separately managed account, beneficially own, pecuniary interest, +1 more
5 terms
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
separately managed account financial
"Securities owned by a separately managed account (the "Managed Account")."
A separately managed account (SMA) is a personalized investment portfolio owned by a single investor and run by a professional manager who buys and sells securities on that investor’s behalf. It matters to investors because an SMA offers tailored asset selection, tax handling, and transparency—like hiring a personal chef who prepares meals to your dietary needs rather than sharing a set menu—so you can align holdings with your goals and see exactly what you own.
beneficially own regulatory
"may be deemed to beneficially own the securities owned directly by the Fund."
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
pecuniary interest regulatory
"disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest"
Section 16(a) regulatory
"for purposes of Section 16(a) of the Securities Exchange Act of 1934"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Opaleye Management report for ETON?
Opaleye Management reported open-market sales of 28,315 Eton Pharmaceuticals shares on July 14, 2026 at a weighted average price of $37.5431 per share, executed through Opaleye, L.P. and a separately managed account.